Althaea Officinalis 4X Homeopathic Medicine Recalled for Failed Identification Testing
Washington Homeopathic Products is recalling Althaea Officinalis 4X, Iritable Bladder homeopathic medicine (Lot # 29377, Exp 8/17/2026) distributed nationwide because testing results failed to meet specifications for product identification.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a homeopathic product with out-of-specification test results for product identification. No illness, injury, or hospitalization is reported in the source text. The hazard is a labeling/identity verification issue without documented harm, warranting a Moderate severity classification.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Althaea Officinalis 4X, Iritable Bladder packaged as Sucrose/Lactose Pills, 4 Dram, WHP Homeopathic Medicine, manufactured at 260 JR Hawvermale Way, Berkeley Springs, WV 25411. The recall affects 10 bottles with Lot # 29377 and expiration date 8/17/2026 that were distributed nationwide in the USA.
The product is being recalled because out-of-specification test results were obtained for identification testing based on HPTLC (High-Performance Thin-Layer Chromatography) analysis. This means the product failed to meet required standards for confirming the identity of the active ingredient.
Consumers who have purchased this product should stop using it and consult their healthcare provider if they have any concerns about their health.
The recalled product
- Product
- Althaea Officinalis 4X, Iritable Bladder* packaged as Sucrose/Lactose Pills, 4 Dram, WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- identification-testing-failure
- out-of-specification
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 29377
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27